Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.


TSXV:XRTX - Post by User

Comment by Richmondon Aug 17, 2021 7:35am
107 Views
Post# 33715716

RE:RE:VOTE YES NASDAQ BABY

RE:RE:VOTE YES NASDAQ BABYAGREE 100% 1000%, 10000000% NO TO ROLLBACK!! NO..NO..NO..NO.. Rollbacks never work. Go to Nasdaq, when Xortex can reach $5.00+ on its product valuations. So many in pipelines. GET ONE PATENTED!!!!!..comeon Intelligence!!!
SpaceLabs wrote:
Iotamaniac1969 wrote: Just voted yes with my 1.89 M shares.  I hear that the 51% is in hand.   hear we go NASDAQ


VOTE NO !, NO!  so we Do Not CHEAT Nasdaq on Listing FEE.

Go to Nasdaq ,we all are in favor BUT on MERITS, you Qualify for the Major with atleast ONE Product that you can MARKET.

Look at the Listing Fee on Nasdaq, Do Not CHEAT with Americans by ROLLINGBACK XRX shareholders
Maniac1969,,,,,,,,,you go and FLUSH your 1.89M shares ,must be an INSIDER who LEAKED the NEWS with Allen CEO,,,,,RNeks who have no HEART.

All the activity and Price JUMP prior to Last Friday,s NR ,,,is very SUSPICIOUS and a CRIME COMMITED by the CEO of XORTX for LEAKING it and NO NR in the Public Domain.

We Do Not know what the Plan is for Rollback of our shares, I own 3.6 Million shares.

Allen CEO, a Scientist not a Business Executive, talk to the shareholders pls by a New Release what your MOTIVES are????



<< Previous
Bullboard Posts
Next >>